WEBSITE TERMS

Clear expectations for visitors.

These terms address use of the public website at tendorya.com. They are not a clinical product license or a substitute for a separate agreement governing Clinical NNN patient-related features.

Published 22 October 2026 · Applies to informational pages only

Purpose of this site

TENDORYA publishes information about its emerging technology brand, areas of interest and early-stage products. Content is provided to help visitors understand the project. Any future concepts are clearly labeled as explorations, not services currently offered.

No clinical advice

Nothing on this website constitutes diagnosis, treatment instructions, an emergency service or medical advice. Nursing classifications require correct edition, context and qualified interpretation. Do not rely on this website to make patient-care decisions.

Intellectual property and external standards

The TENDORYA name, original website text and graphics are project branding materials. NANDA-I, NOC and NIC are third-party nursing classification names and materials with rights held by their respective owners; their appearance does not imply endorsement, affiliation or unrestricted permission to reproduce licensed content.

External links and beta access

Links may take you to third-party services or to the separate Clinical NNN beta application. Those services may have their own conditions and privacy practices. Beta access should be used for evaluation with fictional or suitably de-identified test data until applicable data safeguards and product-specific notices are established.

Availability and updates

The public site is provided on an evolving basis. Pages, content and links may change and there is no promise of uninterrupted availability. Material changes to this informational notice will be reflected by updating its published date.

Before wider release

These introductory terms are not a finalized service contract. Product-specific terms, legal operator identity, jurisdiction and a private contact channel should be reviewed and completed before broad commercial use.